Page 15 - Pharma

IIIM-CSIR opens cGMP plant in Jammu for phyto-pharmaceuticals

The CGMP facility will help in extraction, formulation and packaging of medicinal plant based phyto-pharmaceutical drugs

Huhtamaki PPL to set up plants for flexible packaging and labels in NE India

The company will spend Rs 65 cr to build manufacturing facilities for flexible packaging and labels at Assam and Sikkim respectively. It will also relocate its labels plant in Navi Mumbai

Retail cold chain: Will it work in India?

High operating cost of cold storage - $ 60 per cubic meter in India compared to $ 30 in the west - is one of the major roadblocks for the sector's growth, says Alagu Balaraman

NICPR and All India Institute of Ayurveda ink MoU for cancer research

The two sides will set up a Center of Integrative Oncology at Noida centre of National Institute of Cancer Prevention and Research (NICPR)

Large scale imports of APIs from China worries Indian pharma industry

Overwhelming dependence on China for crucial active pharmaceutical ingredients (APIs) and intermediates has emerged as a main worrying area, as per the Assocham-RNCOS study

Sun Pharma & ICGEB to jointly develop dengue vaccine

The pharma company will fund & support further development of a vaccine candidate developed by International Centre for Genetic Engineering and Biotechnology (ICGEB)

Sabic and PDI conduct study to test medical device plastics

Leaders in thermoplastic technology and infection prevention conducted stress-cracking study to unravel compatibility issues

GE partners Tata Trusts to skill 10,000 youths in healthcare sector

While courses will be undertaken in GE Healthcare Institute in 25 cities, Tata Trusts will provide scholarships to deserving candidates

Air Liquide builds ingredients plant in US for cosmetics and pharma

Expected to start operations in the first half of 2018, the project will witness an investment of over $60 million

Four BRICS Biomed centres to be set up in India by 2025

BRICS-Biomed Consortium, which is also looking at promoting traditional herbal medicine from BRICS, will open these centres in Kanyakumari, Bangalore, Hyderabad and Delhi

J&K's first biotech park to be ready in 18 months

Currently, the project is through for construction at a budget of around Rs 100 crore in the first phase

Prevalence of infectious diseases to propel antibiotics market to reach $ 57 bn

Currently, the required antibiotic treatment is available only to one third of the infected population, thereby increasing the disease burden, says a Grand View Research report

Finnish workwear service firm Lindstrom plans expansion in India

The company aims to double its national presence from 10 to 20 locations by 2020 as manufacturing activities gain momentum in the country

Lupin and Boehringer Ingelheim ink co-marketing pact for diabetes drug empagliflozin

While Lupin will market empagliflozin under the brand name of Gibtulio, Boehringer Ingelheim will continue to sell it under Jardiance brand in India

Mylan agrees for $ 465-mn settlement with US DoJ for EpiPen auto-injector

The company has agreed for the payment to resolve questions that have been raised about the classification of EpiPen auto-injector for purposes of the Medicaid Drug Rebate Program

Dr Reddy's Labs forays into Colombia

The company will launch its portfolio of high quality and affordable medicines for cancer patients in the Colombian pharmaceutical market

Piramal Enterprises buys Janssen's five injectable products for $ 175 mn

The acquisition of anaesthesia and pain management products will enable PEL's critical care division to tap the global generic injectable hospital drug market, which is estimated at about $ 20 bn

Indian biosimilars market to reach $ 40 bn by 2030: Study

With a new regulatory policy and increased affordability offered by biosimilars, the domestic market is expected to grow at an accelerated pace, says a Assocham-Sathguru Management report

Lupin to use MonoSol technology for developing paediatric products

The Mumbai-headquartered will develop multiple paediatric products utilising the US-based MonoSol Rx's proprietary PharmFilm drug delivery technology

Medical value travel industry in India to reach $ 9-bn by 2020: Study

Cost effectiveness and superior outcomes help India to emerge as one of the preferred global medical value travel destinations, says a FICCI-IMS Health study